Sharon Winton, the CEO and director of Lymphoma Australia, said, “Patients living with DLBCL deserve options at every stage of their treatment journey. The availability of another treatment option for patients who have already undergone two or more lines of therapy acknowledges this need and is welcomed by the community.” …
Stakeholders welcome the PBS listing of AbbVie's blood cancer therapy
April 28, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Guilt over this enduring failure is the correct response
September 9, 2026 - -
Poweroos chase world title in Argentina with new backing from Biogen
September 9, 2026 - - Latest News -
What will AI be capable of in two months? We don't know, and that's the point
September 9, 2026 - - Latest News -
'You can't fix a broken system by tinkering with parts of it'
September 9, 2026 - - Latest News -
A review recommendation that should be reconsidered because of time
September 8, 2026 - - Latest News -
The forgotten patients living in the long shadow of rare cancer
September 8, 2026 - - Latest News -
Pharmacists could save women millions and cut GP queues, new analysis shows
September 8, 2026 - - Latest News